Letters to Trade

Third generation aromatase inhibitors (anastrozole, exemestane, letrozole): Assessing the potential risk of tendon disorders (Letter to Healthcare Professionals)

Attachment:

Third generation aromatase inhibitors (anastrozole, exemestane, letrozole): Assessing the potential risk of tendon disorders

Related Information:

Canada: Summary Safety Review: Third generation aromatase inhibitors (anastrozol... Posted 2023-01-18